Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT00488267

Public ClinicalTrials.gov record NCT00488267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 10:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy of ThermoProfen™ in the Treatment of Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee (ZMK-301)

Study identification

NCT ID
NCT00488267
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ZARS Pharma Inc.
Industry
Enrollment
679 participants

Conditions and interventions

Conditions

Interventions

  • ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System) Drug
  • Placebo Matrix/CHADD Patch Drug
  • Ketoprofen matrix/placebo CHADD Patch Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
May 31, 2008
Completion
Aug 31, 2008
Last update posted
May 29, 2012

2007 – 2008

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Not listed Peoria Arizona 85381
Not listed Anaheim California 92801
Not listed Buena Park California 90620
Not listed San Diego California 92103
Not listed Westlake Village California 91361
Not listed Hamden Connecticut 06518
Not listed Milford Connecticut 06460
Not listed Clearwater Florida 33761
Not listed Jupiter Florida 33458
Not listed Pembroke Pines Florida 33024
Not listed South Miami Florida 33143
Not listed Tampa Florida 33614
Not listed Boise Idaho 83704
Not listed Springfield Illinois 62704
Not listed Evansville Indiana 47714
Not listed Overland Park Kansas 66215
Not listed Baltimore Maryland 21239
Not listed Wheaton Maryland 20902
Not listed Lansing Michigan 48910
Not listed Kansas City Missouri 64114
Not listed Mercerville New Jersey 08619
Not listed Greensboro North Carolina 27408
Not listed Raleigh North Carolina 27612
Not listed Lake Oswego Oregon 97035
Not listed Portland Oregon 97239
Not listed Duncansville Pennsylvania 16635
Not listed Erie Pennsylvania 16508
Not listed Mechanicsburg Pennsylvania 17055
Not listed Anderson South Carolina 29621
Not listed Myrtle Beach South Carolina 29572
Not listed Nashville Tennessee 37205
Not listed Houston Texas 77090
Not listed San Antonio Texas 78217
Not listed Salt Lake City Utah 84106
Not listed Spokane Washington 99204
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00488267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2012 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00488267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →